Premium
Cardiovascular effects of AQ‐A 39 in healthy volunteers.
Author(s) -
Hilaire J,
Broustet JP,
Colle JP,
Theron M
Publication year - 1983
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.1983.tb02232.x
Subject(s) - heart rate , placebo , propranolol , blood pressure , medicine , bicycle ergometer , rate pressure product , anesthesia , cardiology , alternative medicine , pathology
Ten healthy male volunteers performed maximal exercise tests on a bicycle ergometer. A control reading was obtained; at a second session propranolol 80 mg was given, and then placebo, 100 mg or 200 mg AQ‐A 39 were administered in a randomised double‐blind manner. At peak exercise, the heart rate averaged 191.6 beats/min during the control test, 185.8 beats/min after placebo, 172.4 beats/min with 100 mg of AQ‐ A 39 (‐10%), 166.0 (beats/min) with 200 mg of AQ‐A 39 (‐13.4%); with 80 mg of propranolol, the heart rate averaged 132.8 beats/min and the workload accomplished was substantially lower than that accomplished with AQ‐A 39 and placebo which remained the same as in the control test. No effect on blood pressure was observed. The rate pressure product was significantly reduced with AQ‐A 39.